Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Inova Skincare ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6%   Bankruptcy risk   2.4% 1.4% 8.5% 10.4% 14.0% 14.5% 16.7% 16.7%   Credit score (0-100)   65 79 29 22 15 14 10 10   Credit rating   BBB A BB BB BB BB BB BB   Credit limit (kDKK)   0.0 21.1 0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,959 2,825 -537 -502 -734 -948 0.0 0.0   EBITDA   2,108 1,613 -1,612 -1,372 -1,131 -1,492 0.0 0.0   EBIT   1,946 1,276 -2,112 -1,921 -4,883 -1,510 0.0 0.0   Pre-tax profit (PTP)   1,942.5 1,269.9 -2,154.9 -2,095.8 -5,139.1 -1,858.2 0.0 0.0   Net earnings   1,503.5 989.7 -1,687.7 -2,409.4 -5,139.1 -1,858.2 0.0 0.0   Pre-tax profit without non-rec. items   1,943 1,270 -2,155 -2,096 -5,139 -1,858 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   430 451 386 320 255 46.5 0.0 0.0   Shareholders equity total   1,619 2,609 922 -1,488 -6,627 -8,485 -8,565 -8,565   Interest-bearing liabilities   0.1 897 3,395 5,556 6,997 8,576 8,565 8,565   Balance sheet total (assets)   2,607 4,525 4,950 4,316 387 118 0.0 0.0   Net Debt   -613 595 3,248 5,392 6,930 8,518 8,565 8,565     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,959 2,825 -537 -502 -734 -948 0.0 0.0   Gross profit growth   175.6% -4.5% 0.0% 6.5% -46.3% -29.0% 0.0% 0.0%   Employees   0 0 0 2 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,607 4,525 4,950 4,316 387 118 0 0   Balance sheet change%   112.2% 73.6% 9.4% -12.8% -91.0% -69.6% -100.0% 0.0%   Added value   2,107.9 1,613.0 -1,612.2 -1,371.9 -4,333.8 -1,492.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,321 1,744 -278 -840 -7,504 -226 -46 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   65.8% 45.2% 393.5% 382.7% 664.9% 159.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   101.5% 35.8% -44.6% -35.7% -76.2% -19.3% 0.0% 0.0%   ROI %   181.3% 47.9% -53.0% -38.9% -77.8% -19.4% 0.0% 0.0%   ROE %   147.8% 46.8% -95.6% -92.0% -218.5% -736.1% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   62.1% 57.7% 18.6% -25.6% -94.5% -98.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -29.1% 36.9% -201.5% -393.0% -612.6% -570.8% 0.0% 0.0%   Gearing %   0.0% 34.4% 368.4% -373.4% -105.6% -101.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   17.2% 1.7% 2.0% 3.9% 4.1% 4.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.7 0.2 0.2 0.1 0.0 0.0 0.0 0.0   Current Ratio   0.7 0.2 0.2 0.1 0.0 0.0 0.0 0.0   Cash and cash equivalent   613.0 302.1 146.9 164.3 67.2 57.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -325.6 -1,376.7 -3,375.6 -5,494.8 -6,882.0 -8,531.7 -4,282.6 -4,282.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 -686 -2,167 -1,492 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 -686 -566 -1,492 0 0   EBIT / employee   0 0 0 -961 -2,442 -1,510 0 0   Net earnings / employee   0 0 0 -1,205 -2,570 -1,858 0 0